支气管肺泡灌洗液对肺结节鉴别诊断的临床意义
支气管肺泡灌洗液对肺结节鉴别诊断的临床意义
肺癌是我国发病率及病死率均位于第一的恶性肿瘤[1]。目前,肺癌的五年生存率约为22%,其中晚期肺癌五年生存率仅为6%,而早期肺癌五年生存率高达60%[1]。因此,肺癌早期诊断是改善其预后的关键。通过胸部影像学筛查肺部结节是早期发现肺癌的基本途径,目前对肺结节的性质判定主要基于肺结节的形态特征和动态观察。近年来,液态活检凭借其无/低创性、高灵敏度、易于动态观察等优势在肿瘤的早期诊断、疗效监测等方面展现出巨大潜力,受到广泛关注。
书籍广告
一、肺癌早期诊断现状及存在问题
二、基于BALF液态活检的诊断技术进展
三、总结与展望
参考文献
[1]
SiegelRL, MillerKD, FuchsHE, et al. Cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72(1):7-33. DOI: 10.3322/caac.21708.
[2]
FanL, WangY, ZhouY, et al. Lung Cancer Screening with Low-Dose CT: Baseline Screening Results in Shanghai[J]. Acad Radiol, 2019, 26(10):1283-1291. DOI: 10.1016/j.acra.2018.12.002.
[3]
唐威, 吴宁, 黄遥, 等. 4690例无症状健康体检者低剂量CT早期肺癌筛查研究[J]. 中华肿瘤杂志, 2014, 36(7):549-554. DOI: 10.3760/cma.j.issn.0253-3766.2014.07.016.
[4]
YangW, QianF, TengJ, et al. Community-based lung cancer screening with low-dose CT in China: Results of the baseline screening[J]. Lung Cancer, 2018, 117:20-26. DOI: 10.1016/j.lungcan.2018.01.003.
[5]
LiuY, LuoH, QingH, et al. Screening baseline characteristics of early lung cancer on low-dose computed tomography with computer-aided detection in a Chinese population[J]. Cancer Epidemiol, 2019, 62:101567. DOI: 10.1016/j.canep.2019.101567.
[6]
AberleDR, AdamsAM, BergCD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening[J]. N Engl J Med, 2011, 365(5):395-409. DOI: 10.1056/NEJMoa1102873.
[7]
FieldJK, VulkanD, DaviesM, et al. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis[J]. Lancet Reg Health Eur, 2021, 10:100179. DOI: 10.1016/j.lanepe.2021.100179.
[8]
BachPB, MirkinJN, OliverTK, et al. Benefits and harms of CT screening for lung cancer: a systematic review[J]. JAMA, 2012, 307(22):2418-2429. DOI: 10.1001/jama.2012.5521.
[9]
RampinelliC, De MarcoP, OriggiD, et al. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis[J]. BMJ, 2017, 356:j347. DOI: 10.1136/bmj.j347.
[10]
van den BerghKA, Essink-BotML, BungeEM, et al. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial)[J]. Cancer, 2008, 113(2):396-404. DOI: 10.1002/cncr.23590.
[11]
PlankA, GoldgrabenS, NemesureB. Prevalence and risk factors of elevated distress among patients undergoing screening for lung cancer[J]. Chest, 2015, 148(4). DOI: 10.1378/chest.2244559.
[12]
中华医学会呼吸病学分会肺癌学组, 中国肺癌防治联盟专家组. 肺结节诊治中国专家共识(2018年版)[J]. 中华结核和呼吸杂志, 2018, 41(10):763-771. DOI: 10.3760/cma.j.issn.1001-0939.2018.10.004.
[13]
Fremont-SmithM, GrahamRM, MeigsJV. Early diagnosis of cancer by study of exfoliated cells[J]. J Am Med Assoc, 1948, 138(7):469-474. DOI: 10.1001/jama.1948.02900070001001.
[14]
LiuY, XuH, LiT, et al. Microtechnology-enabled filtration-based liquid biopsy: challenges and practical considerations[J]. Lab Chip, 2021, 21(6):994-1015. DOI: 10.1039/d0lc01101k.
[15]
LiT, LiuY, ZhangW, et al. A rapid liquid biopsy of lung cancer by separation and detection of exfoliated tumor cells from bronchoalveolar lavage fluid with a dual-layer "PERFECT" filter system[J]. Theranostics, 2020, 10(14):6517-6529. DOI: 10.7150/thno.44274.
[16]
LiuY, LiT, XuM, et al. A high-throughput liquid biopsy for rapid rare cell separation from large-volume samples[J]. Lab Chip, 2018, 19(1):68-78. DOI: 10.1039/c8lc01048j.
[17]
LiuY, XuH, DaiW, et al. 2.5-Dimensional Parylene C micropore array with a large area and a high porosity for high-throughput particle and cell separation[J]. Microsyst Nanoeng, 2018, 4:13. DOI: 10.1038/s41378-018-0011-8.
[18]
BezelP, TischlerV, RobinsonC, et al. Diagnostic Value of Bronchoalveolar Lavage for Diagnosis of Suspected Peripheral Lung Cancer[J]. Clin Lung Cancer, 2016, 17(5):e151-e156. DOI: 10.1016/j.cllc.2015.12.012.
[19]
陶伟, 李俊, 程柳柳. 细胞 DNA 定量分析技术在肺癌诊断中的应用价值[J]. 中华肿瘤杂志, 2016, 38(2):113-117. DOI: 10.3760/cma.j.issn.0253-3766.2016.02.007.
[20]
ZhangC, YuW, WangL, et al. DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis[J]. J Cancer, 2017, 8(17):3585-3591. DOI: 10.7150/jca.21368.
[21]
RenM, WangC, ShengD, et al. Methylation analysis of SHOX2 and RASSF1A in bronchoalveolar lavage fluid for early lung cancer diagnosis[J]. Ann Diagn Pathol, 2017, 27:57-61. DOI: 10.1016/j.anndiagpath.2017.01.007.
[22]
ShiA, MinW, XiangL, et al. Value of automatic DNA image cytometry for diagnosing lung cancer[J]. Oncol Lett, 2018, 16(1):915-923. DOI: 10.3892/ol.2018.8723.
[23]
颜云. DNA定量分析在支气管镜刷检及肺泡灌洗液中的应用价值[J].临床与病理杂志, 2019, 39(2):353-357. DOI: 10.3978/j.issn.2095-6959.2019.02.020.
[24]
陈瑞英, 刘雅, 孙婷, 等. 支气管肺泡灌洗液中SHOX2和RASSF1A基因甲基化检测对肺癌的诊断价值[J].郑州大学学报(医学版), 2019, 54(5):732-736. DOI: 10.13705/j.issn.1671-6825.2019.03.005.
[25]
陈学敬, 周立娟, 杜伟丽, 等. 细胞DNA定量分析技术在肺癌诊断中的应用价值[J].中华临床医师杂志(电子版)2021, 15(5):331-334. DOI: 10.3877/cma.j.issn.1674-0785.2021.05.003.
[26]
ZengD, WangC, MuC, et al. Cell-free DNA from bronchoalveolar lavage fluid (BALF): a new liquid biopsy medium for identifying lung cancer[J]. Ann Transl Med, 2021, 9(13):1080. DOI: 10.21037/atm-21-2579.
[27]
ZhangX, KuangY, ZhangY, et al. Shifted focus of bronchoalveolar lavage in patients with suspected thoracic malignancy: an analysis of 224 patients[J]. J Thorac Dis, 2016, 8(11):3245-3254. DOI: 10.21037/jtd.2016.11.06.
[28]
BhatN, NazeirM, BashirH, et al. Correlation of bronchial biopsy with bronchoalveolar lavage in lung malignancies[J]. Int J Res Med Sci, 2016, 4(2):428-435. DOI: 10.18203/2320-6012.ijrms20160290.
[29]
RennardSI. Bronchoalveolar lavage in the diagnosis of cancer[J]. Lung, 1990, 168Suppl:1035-1040. DOI: 10.1007/BF02718241.
[30]
郑亮, 亓玉心, 周玉法. 支气管肺泡灌洗液联合TCT在周围型肺癌诊断中的应用[J]. 现代肿瘤医学, 2017, 25(10):1572-1574. DOI: 10.3969/j.issn.1672-4992.2017.10.015.
[31]
中华人民共和国国家卫生健康委员会. WS/T 459—2018 常用血清肿瘤标志物检测的临床应用和质量管理[S]. 2018.
[32]
CremadesMJ, MenéndezR, PastorA, et al. Diagnostic value of cytokeratin fragment 19 (CYFRA 21-1) in bronchoalveolar lavage fluid in lung cancer[J]. Respir Med, 1998, 92(5):766-771. DOI: 10.1016/s0954-6111(98)90010-5.
[33]
BineshF, PirdehghanA, MirjaliliMR, et al. Comparative assessment of the diagnostic value of transbronchial lung biopsy and bronchoalveolar lavage fluid cytology in lung cancer[J]. Asian Pac J Cancer Prev, 2015, 16(1):201-204. DOI: 10.7314/apjcp.2015.16.1.201.
[34]
RobertsonKD. DNA methylation and human disease[J]. Nat Rev Genet, 2005, 6(8):597-610. DOI: 10.1038/nrg1655.
[35]
PonomaryovaAA, RykovaEY, CherdyntsevaNV, et al. Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients[J]. Lung Cancer, 2013, 81(3):397-403. DOI: 10.1016/j.lungcan.2013.05.016.
[36]
NunesSP, DinizF, Moreira-BarbosaC, et al. Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies[J]. J Clin Med, 2019, 8(9). DOI: 10.3390/jcm8091500.
[37]
ZhangY, WangR, SongH, et al. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer[J]. Cancer Lett, 2011, 303(1):21-28. DOI: 10.1016/j.canlet.2010.12.011.
[38]
KneipC, SchmidtB, SeegebarthA, et al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma[J]. J Thorac Oncol, 2011, 6(10):1632-1638. DOI: 10.1097/JTO.0b013e318220ef9a.
[39]
HuangW, HuangH, ZhangS, et al. A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer[J]. Cancer Control, 2020, 27(1):1073274820969703. DOI: 10.1177/1073274820969703.
[40]
SchottenLM, DarwicheK, SewerynM, et al. DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients[J]. Eur J Cancer, 2021, 147:142-150. DOI: 10.1016/j.ejca.2021.01.032.
[41]
WeiB, WuF, XingW, et al. A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer[J]. Sci Rep, 2021, 11(1):16782. DOI: 10.1038/s41598-021-96242-6.
[42]
ZangR, WangX, JinR, et al. Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity[J]. J Transl Med, 2019, 17(1):430. DOI: 10.1186/s12967-019-2117-7.
[43]
FengX, XieX, ZhengB, et al. The more potential performance of nidogen 2 methylation by tissue or plasma DNA over brichoalveolar lavage DNA in diagnosis of nonsmall cell lung cancer[J]. J Cancer Res Ther, 2018, 14(Supplement):S341-S346. DOI: 10.4103/0973-1482.235352.
[44]
梁莹, 肖祖克, 吴西雅. 电子支气管镜联合TFPI-2基因甲基化检测对早期肺癌的诊断价值[J].江西医药, 2021, 56(3):284-286. DOI: 10.3969/j.issn.1006-2238.2021.03.006.
[45]
段鸿飞, 傅瑜, 李琦, 等. 支气管灌洗液抑癌基因过甲基化对肺癌诊断价值的研究[J].中国防痨杂志, 2009, 31(5):277-283.
[46]
DongS, LiW, WangL, et al. Histone-Related Genes Are Hypermethylated in Lung Cancer and Hypermethylated HIST1H4F Could Serve as a Pan-Cancer Biomarker[J]. Cancer Res, 2019, 79(24):6101-6112. DOI: 10.1158/0008-5472.CAN-19-1019.
[47]
田祺, 赵靖, 刘菲菲, 等. 支气管肺泡灌洗液SHOX2和RASSF1A基因甲基化检测在临床肺癌早期诊断中的应用[J]. 中国老年学杂志, 2020, 40(17):3629-3632. DOI: 10.3969/j.issn.1005-9202.2020.17.015.
[48]
LiL, YeZ, YangS, et al. Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids[J]. Clin Epigenetics, 2021, 13(1):185. DOI: 10.1186/s13148-021-01163-w.
[49]
ChowdhuriSR, XiL, PhamTH-T, et al. EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection[J]. Mod Pathol, 2012, 25(4):548-555. DOI: 10.1038/modpathol.2011.184.
[50]
ScarpaA, SikoraK, FassanM, et al. Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel[J]. PLoS One, 2013, 8(11):e80478. DOI: 10.1371/journal.pone.0080478.
[51]
StigtJA, ′tHartNA, KnolAJ, et al. Pyrosequencing analysis of EGFR and KRAS mutations in EUS and EBUS-derived cytologic samples of adenocarcinomas of the lung[J]. J Thorac Oncol, 2013, 8(8):1012-1018. DOI: 10.1097/JTO.0b013e31829ce93e.
[52]
CasadioC, GuarizeJ, DonghiS, et al. Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle Aspiration[J]. Am J Clin Pathol, 2015, 144(4):629-634. DOI: 10.1309/AJCPXGRAIMB4CTQ3.
[53]
YamaguchiF, KugawaS, TatenoH, et al. Analysis of EGFR, KRAS and P53 mutations in lung cancer using cells in the curette lavage fluid obtained by bronchoscopy[J]. Lung Cancer, 2012, 78(3):201-206. DOI: 10.1016/j.lungcan.2012.08.014.
[54]
AkamatsuH, KohY, KenmotsuH, et al. Multiplexed molecular profiling of lung cancer using pleural effusion[J]. J Thorac Oncol, 2014, 9(7):1048-1052. DOI: 10.1097/JTO.0000000000000203.
[55]
ButtittaF, FelicioniL, Del GrammastroM, et al. Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing[J]. Clin Cancer Res, 2013, 19(3):691-698. DOI: 10.1158/1078-0432.CCR-12-1958.
[56]
CaoC, ChenZB, SunSF, et al. Evaluation of VEGF-C and tumor markers in bronchoalveolar lavage fluid for lung cancer diagnosis[J]. Sci Rep, 2013, 3:3473. DOI: 10.1038/srep03473.
[57]
BiaoxueR, XiguangC, HuaL, et al. Increased level of annexin A1 in bronchoalveolar lavage fluid as a potential diagnostic indicator for lung cancer[J]. Int J Biol Markers, 2017, 32(1):e132-e140. DOI: 10.5301/jbm.5000243.
[58]
SimSY, ChoiYR, LeeJH, et al. In-Depth Proteomic Analysis of Human Bronchoalveolar Lavage Fluid toward the Biomarker Discovery for Lung Cancers[J]. Proteomics Clin Appl, 2019, 13(5):e1900028. DOI: 10.1002/prca.201900028.
[59]
HmmierA, O′BrienME, LynchV, et al. Proteomic analysis of bronchoalveolar lavage fluid (BALF) from lung cancer patients using label-free mass spectrometry[J]. BBA Clin, 2017, 7:97-104. DOI: 10.1016/j.bbacli.2017.03.001.
[60]
YossEB, BerdD, CohnJR, et al. Flow cytometric evaluation of bronchoscopic washings and lavage fluid for DNA aneuploidy as an adjunct in the diagnosis of lung cancer and tumors metastatic to the lung[J]. Chest, 1989, 96(1):54-59. DOI: 10.1378/chest.96.1.54.
[61]
陶敏, 李建勇, 吴洁, 等. 支气管冲洗和肺泡灌洗液细胞DNA含量分析对肺癌的诊断价值[J].中华结核和呼吸杂志, 1996, 19(4):222-225.
[62]
HallingKC, KippBR. Fluorescence in situ hybridization in diagnostic cytology[J]. Hum Pathol, 2007, 38(8):1137-1144. DOI: 10.1016/j.humpath.2007.04.015.
[63]
LindemanNI, CaglePT, AisnerDL, et al. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the college of American Pathologists, the international association for the study of lung cancer, and the association for molecular pathology[J]. Arch Pathol Lab Med, 2018, 142(3):321-346. DOI: 10.5858/arpa.2017-0388-CP.
[64]
ZhongCH, TongD, ZhouZQ, et al. Performance evaluation of detecting circulating tumor cells and tumor cells in bronchoalveolar lavage fluid in diagnosis of peripheral lung cancer[J]. J Thorac Dis, 2018, 10(Suppl 7):S830-S837. DOI: 10.21037/jtd.2017.12.125.
[65]
ZhongM, ZhangY, PanZ, et al. Clinical Utility of Circulating Tumor Cells in the Early Detection of Lung Cancer in Patients with a Solitary Pulmonary Nodule[J]. Technol Cancer Res Treat, 2021, 20:15330338211041465. DOI: 10.1177/15330338211041465.
常规皮试假阳性率达94.1%?“青霉素过敏史”主诉患者规范化青霉素过敏检测
血气分析
认识第五生命体征:血氧饱和度( SO2 )!SpO2≠SaO2?
扩张钳式(PORTEX Griggs) 经皮气管造口技术(图文+视频)
经皮气管切开术(手术步骤、注意事项、术后护理)(图文+视频)
我国首部急救科普三维动画视频---心肺复苏,学会可救人一命!
自动体外除颤器(AED)如何操作?非常简单,3分钟视频学会!
CT和腰椎穿刺正常的爆裂样头痛患者没有必要进行更深入检查吗?
以单侧胸腔积液入院,发现多浆膜腔积液,这种鉴别诊断你还记得吗?
47岁女患者,长期透析-发热-左下肢疼痛-肺内结节,原因何在?